NCT03923933View on ClinicalTrials.gov

Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

October 28, 2019

Study Completion Date

October 28, 2019

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

Chlorthalidone

Chlorthalidone

DRUG

Bumetanide

Bumetanide

Trial Locations (1)

06720

Hospital General de Mexico, Mexico City

All Listed Sponsors
lead

Hospital General de México Dr. Eduardo Liceaga

OTHER_GOV

NCT03923933 - Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial | Biotech Hunter | Biotech Hunter